The Folic Acid–Dairy Synergy Hypothesis (FADSH): A Proposed Multi-Vector Mechanism for Folate Receptor Alpha Autoimmunity Through Industrial Milk Processing and Synthetic Folate Exposure

Folate receptor alpha (FRα) autoantibodies (FRAAs) have been identified in approximately 70% of children with autism spectrum disorder (ASD) and are the primary known cause of cerebral folate deficiency (CFD)—a condition in which brain folate levels are critically depleted despite normal serum folate. Two independent lines of research have implicated (a) bovine milk folate-binding protein (FBP) as a molecular mimicry trigger for FRAA production, and (b) synthetic folic acid (pteroylglutamic acid) as a source of unmetabolized folic acid (UMFA) that competes with natural folate for receptor binding. However, these mechanisms have been studied in isolation.This paper proposes the Folic Acid–Dairy Synergy Hypothesis (FADSH), which posits that the convergence of three modern industrial innovations—mandatory folic acid food fortification (1998), commercial dairy pasteurization, and synthetic folic acid supplementation in cattle feed—creates a novel, multi-vector immunological insult to FRα. The hypothesis integrates evidence on UMFA’s preferential binding affinity for FRα, the differential thermal stability of folic acid–FBP complexes during pasteurization, the structural basis for bovine–human FRα cross-reactivity, and the role of gut barrier compromise in antigen presentation.The FADSH generates six specific, testable predictions distinguishing it from existing single-mechanism models, including that FRAA prevalence should be highest in populations with both folic acid fortification and pasteurized dairy consumption, and that the biochemical distinctions between raw milk from grass-fed cattle and industrially processed dairy warrant investigation as immunologically relevant variables. The hypothesis addresses one mechanism within the multifactorial etiology of cerebral folate deficiency and does not propose a singular cause of autism spectrum disorder.